News
1d
News-Medical.Net on MSNNUS researchers develop breakthrough gene delivery technology for immune cellsResearchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently delivers genetic material into human immune cells. The platform, called ...
Contributing to Singapore’s collective memory-making, a team led by Singapore Management University’s (SMU) environmental historian Fiona Williamson has completed the first-ever historical overview of ...
Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for ...
Jindal Poly Films,Hindustan Zinc,Data Patterns (India), Zinka Logistics Solutions, KPR Mill, Aarti Industries, Birlasoft, ...
Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market's listing surge ...
[SINGAPORE] Biotechnology company Nuevocor announced on Wednesday (May 7) that it completed a US$45 million Series B funding round from new and existing investors. This includes “significant ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
Pursuant to this collaboration agreement, CK Health will market and sell to EUDA customers in Singapore and Malaysia stem cell therapies provided by Guangdong Cell Biotech in China. This revised ...
As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...
"This strategic collaboration with Thermo Fisher Scientific marks a major milestone in our mission to drive biotech innovation in Singapore," said Ms. Daphne Teo, Founder and Chairwoman of NSG BIO.
This collaboration aims to empower biotech startups in Singapore with access to critical resources, advanced laboratory solutions, and scientific expertise to accelerate their research and ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results